7.5

CVE-2019-13157: naver corporation naver vaccine

Modified
Published 22-11-2019Last modified 04-08-2024

Vulnerability summary

CVE-2019-13157 is a high (CVSS 7.5) vulnerability in naver corporation naver vaccine. EPSS estimates a 1.65% chance of exploitation in the next 30 days, higher than 76.6% of scored vulnerabilities.

Priority
Prioritisesevere

Severe, CVSS 7.5 (NVD); no exploitation reported by the 5 checked sources; EPSS 2% (FIRST, 03-11-2026)

Source freshness unavailable

How is this decided?
CVSS score
7.5/10
010
High · v3.1 (NVD)
EPSS score
1.65%
0%100%
Low · 0.00 pp in 30 days
KEVNot listedNot listed by any tracked catalog.
RansomwareNot flaggedNo ransomware use recorded.
Public exploits0No public exploits recorded

Timeline

  1. 22-11-2019
    PublishedVulnerability first disclosed.
  2. 04-08-2024
    Last modifiedVulnerability information updated.

Description

nsGreen.dll in Naver Vaccine 2.1.4 allows remote attackers to overwrite arbitary files via directory traversal sequences in a filename within nsz archive.

CVSS metrics

2 scores · 1 source · 2 versions

EPSS trend

Probability

1.65%

Chance of exploitation in the next 30 days

Percentile

77%

Versus all other CVEs

30-day change

No change 0.00 pp

From 1.65% on 04-10-2026

04-10-202603-11-2026

Known exploited

Compare KEV catalogs
CISA KEV

Not in the CISA KEV catalog.

ENISA CNW

Not in the ENISA CNW catalog.

CIRCL

Not in the CIRCL catalog.

Public exploits

0 found

No public exploits indexed.

Weaknesses

CWE · root cause

Affected systems

Version check

Known conditions: network-reachable, no authentication, no user interaction (CVSS vector). Other conditions: not stated in public data.

Naver1 product
Naver corporation1 product

2 vendors · 2 products

References

1 links